Perera A.
68
Coauthors
5
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2015 | 1 |
| 2016 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Cáncer | 2 |
| Farmacología | 2 |
| Inmunología | 1 |
| Enfermedad cardiovascular | 1 |
| Biología molecular | 1 |
| Ensayo clínico | 1 |
| Medicina interna | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 5 |
| Farmacología y terapéutica | 5 |
| Fisiología humana | 1 |
| Ginecología, obstetricia, pediatría, geriatría | 1 |
| Medicina y salud | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 5 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Tania Crombet | 3 |
| Batista J.F. | 3 |
| Prats A. | 2 |
| Quián Y.P. | 2 |
| Coca M.A. | 2 |
| Torres L. | 2 |
| Neninger Vinageras E. | 2 |
| Reima C. | 1 |
| Silva R. | 1 |
| Seralena A. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Immunoscintigraphy with <sup>99m</sup>Tc-nimotuzumab for planning immunotherapy in patients with bone metastases due to prostate cancer
ArticleAbstract: Detection of bone metastases indicates poor prognosis for patients with prostate cancer. The immunotPalabras claves:Bone metastases, Immunoscintigraphy, Monoclonal antibody, nimotuzumab, Prostate cancerAutores:Batista J.F., Perera A., Prats A., Quián Y.P., Tania CrombetFuentes:scopusPharmacological Evaluation of Humanized Anti-Epidermal Growth Factor Receptor, Monoclonal Antibody h-R3, in Patients With Advanced Epithelial-Derived Cancer
ArticleAbstract: Epidermal growth factor receptor (EGFR) overexpression has been detected in many tumors of epitheliaPalabras claves:Epidermal growth factor receptor, Monoclonal antibody, Phase I clinical trialAutores:Catala M., Iznaga N., Lage Davila A., Neninger Vinageras E., Perera A., Pérez R., Solano M., Tania Crombet, Torres F., Torres L., Torres O.Fuentes:scopusPhase i/ii clinical trial of the humanized anti-egf-r monoclonal antibody h-r3 labelled with <sup>99m</sup>tc in patients with tumour of epithelial origin
ArticleAbstract: To evaluate the biodistribution, internal radiation dosimetry and toxicity of the humanized MAb h-R3Palabras claves:biodistribution, Dosimetry, Humanized MAb, RadioimmunodiagnosisAutores:Aguilar V., Batista J.F., Coca M.A., Hernández A., Iznaga-Escobar N., Neninger Vinageras E., Perera A., Pérez M., Ramos M., Romero S., Sánchez E., Tania Crombet, Torres L.Fuentes:scopusIntramyocardial gene transfer of vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart
ArticleAbstract: Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen that is angiogenicPalabras claves:Collateral development, Coronary artery disease, Gene therapy, Naked plasmid DNA, revascularization, Therapeutic angiogenesisAutores:Alí A., Batista J.F., Chaos N., Coca M., Dominguez H., Garcia-Osuna T., González N., González R., Guevara L., Herrera L., Montequín J.F., Ojalvo A.G., Perera A., Puchades Y., Quián Y.P., Reima C., Reyes J.L., Santiago Nelson Vispo, Seralena A., Silva R., Vazquez R.Fuentes:scopusOptimizing CIGB-300 intralesional delivery in locally advanced cervical cancer
ArticleAbstract: Background:We conducted a phase 1 trial in patients with locally advanced cervical cancer by injectiPalabras claves:B23/nucleophosmin, Cervical Cancer, CIGB-300, tumour uptakeAutores:Acevedo B.E., Alonso D.F., Ancízar J.A., Baladron I., Casacó C.A., Coca M.A., García I., Gómez R., González L.J., González Y.M., Hernández I., I. Howland-Álvarez, López-Saura P.A., Martínez Y.M., Molina L., Perea-Rodríguez S.E., Perera A., Perera Y., Prats A., Reyes V., Solares M., Torres L.A., Valenzuela-Silva C.M.Fuentes:scopus